Chimin Health Management Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
October 21, 2020 at 03:55 am EDT
Share
Chimin Health Management Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 605.110 million compared to CNY 578.240 million a year ago. Operating income was CNY 58.899 million compared to CNY 61.182 million a year ago. Net income was CNY 34.837 million compared to CNY 41.278 million a year ago. Basic earnings per share from continuing operations was CNY 0.11 compared to CNY 0.13 a year ago.
Chimin Health Management Co., Ltd., formerly Zhejiang Chimin Pharmaceutical CO., Ltd, is primarily engaged in the research, development, manufacture and sale of infusion and injection and puncture machinery products. The Company primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The Company distributes its products within domestic market and to overseas markets.
CHIMIN HEALTH MANAGEMENT CO., LTD. 
